ProCE Banner Activity

Managing Immune-Related Adverse Events: A Nursing Perspective

Multimedia
Join us for an interactive presentation by Kaitlyn Francese, MSN, RN, OCN, on the nurse’s role in managing immune-related adverse events associated with the use of immune checkpoint inhibitors in urothelial cancer.

Released: May 28, 2021

Expiration: May 27, 2022

No longer available for credit.

Share

Faculty

Arjun Balar

Arjun Balar, MD

Associate Professor of Medicine
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Kaitlyn Francese

Kaitlyn Francese, MSN, RN, OCN

Senior Nurse Clinician
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Pfizer and EMD Serono

Learning Objectives

  • Incorporate guideline and expert recommendations to optimally manage adverse events associated with the use of immune checkpoint inhibitors

Faculty Disclosure

Primary Author

Arjun Balar, MD

Associate Professor of Medicine
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Arjun Balar, MD, has disclosed that he has received consulting fees from AstraZeneca/MedImmune, Bristol-Myers Squibb, Genentech, Immunomedics/Gilead Sciences, Incyte, Istari, Janssen, Merck, Nektar, Pfizer, and Seagen; has received funds for research support paid to his institution from AstraZeneca/MedImmune, Genentech, Immunomedics/Gilead Sciences, Merck, Nektar, and Seagen; and has ownership interest in EpiVax.

Kaitlyn Francese, MSN, RN, OCN

Senior Nurse Clinician
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Kaitlyn Francese, MSN, RN, OCN, has disclosed that she has received consulting fees from Seattle Genetics/Astellas.

Staff Disclosure

Staff

Jason J. Everly, PharmD

Jason Everly, PharmD, BCOP, CHCP, has no relevant conflicts of interest to disclose.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no relevant conflicts of interest to disclose.

Jim Mortimer,

Product Director, Hematology/Oncology
Clinical Care Options, LLC

Jim Mortimer has no relevant conflicts of interest to disclose.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no relevant conflicts of interest to disclose.

Shara Pantry, PhD

Associate Scientific Director

Shara Pantry, PhD, has no relevant conflicts of interest to disclose.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy Quill, PhD, has no relevant conflicts of interest to disclose.

Kristen Rosenthal, PhD

Clinical Editor

Kristen Rosenthal, PhD, has no relevant conflicts of interest to disclose.